| 产品编号 | CFN60060 | |
| CAS编号 | 923564-51-6 | |
| 分子式 = 分子量 | C47H55ClF3N5O6S3 = 974.61 | |
| 产品纯度 | >=98% | |
| 物理属性 | Powder | |
| 化合物类型 | Alkaloids | |
| 植物来源 | ||
| ChemFaces的产品在影响因子大于5的优秀和顶级科学期刊中被引用 | ||
| 产品名称 | 产品编号 | CAS编号 | 包装 | QQ客服 |
| 生根粉263 | CFN60060 | 923564-51-6 | 1mg | QQ客服:215959384 |
| 生根粉263 | CFN60060 | 923564-51-6 | 5mg | QQ客服:215959384 |
| 生根粉263 | CFN60060 | 923564-51-6 | 10mg | QQ客服:215959384 |
| 生根粉263 | CFN60060 | 923564-51-6 | 20mg | QQ客服:215959384 |
Cell. 2018 Jan 11;172(1-2):249-261.e12. doi: 10.1016/j.cell.2017.12.019.IF=36.216(2019)
Cell Metab. 2020 Mar 3;31(3):534-548.e5. doi: 10.1016/j.cmet.2020.01.002.IF=22.415(2019)
Mol Cell. 2017 Nov 16;68(4):673-685.e6. doi: 10.1016/j.molcel.2017.10.022.IF=14.548(2019)| Description: | Navitoclax (ABT-263) is a potent inhibitor of Bcl-xL, Bcl-2 and Bcl-w with Ki of ≤ 0.5 nM, ≤1 nM and ≤1 nM in cell-free assays, but binds more weakly to Mcl-1 and A1. | |||
| Targets: | Bcl-xL/Bcl-2/Bcl-w | |||
| In vitro: |
|
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 1.0261 mL | 5.1303 mL | 10.2605 mL | 20.521 mL | 25.6513 mL |
| 5 mM | 0.2052 mL | 1.0261 mL | 2.0521 mL | 4.1042 mL | 5.1303 mL |
| 10 mM | 0.1026 mL | 0.513 mL | 1.0261 mL | 2.0521 mL | 2.5651 mL |
| 50 mM | 0.0205 mL | 0.1026 mL | 0.2052 mL | 0.4104 mL | 0.513 mL |
| 100 mM | 0.0103 mL | 0.0513 mL | 0.1026 mL | 0.2052 mL | 0.2565 mL |
| 产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
| 天仙子胺; Hyoscyamine | CFN00232 | 101-31-5 | C17H23NO3 = 289.37 | 20mg | QQ客服:1457312923 |
| 鸢尾黄素-7-O-木糖基葡萄糖苷; Tectorigenin 7-O-xylosylglucoside | CFN90784 | 231288-19-0 | C27H30O15 = 594.5 | 5mg | QQ客服:2056216494 |
| Hederacolchiside E; Hederacolchiside E | CFN93231 | 33783-82-3 | C65H106O30 = 1367.53 | 5mg | QQ客服:2056216494 |
| 肉苁蓉苷A; Cistanoside A | CFN90526 | 93236-42-1 | C36H48O20 = 800.75 | 20mg | QQ客服:2159513211 |